Headquartered in Dallas, TX Fiscal year ends December NYSE: KMB kimberly-clark.com
Kimberly-Clark Corporation is a global consumer products company that manufactures and markets essential personal care, consumer tissue, and professional products. Its portfolio of brands — including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Pull-Ups, Goodnites, Intimus, Plenitud, Sweety, Softex, Viva, and WypAll — holds No. 1 or No. 2 market share positions in approximately 70 countries, serving consumers in more than 175 countries and territories. The company operates through two primary segments: North America and International Personal Care. Kimberly-Clark is currently undergoing a strategic transformation under its 'Powering Care' strategy, which includes a pending acquisition of Kenvue (expected to close by year-end 2026), a strategic joint venture with Suzano called Arbex, and investment in next-generation sustainable materials through an alternative natural fibers pilot plant. The company is also in the process of separating its International Family Care and Professional business through a joint venture transaction with Suzano. Updated
Some of the most boring products in your grocery cart have quietly funded dividend streaks stretching back decades, and five companies selling those exact staples are still raising payouts even as their…
Kimberly-Clark has raised its dividend for over five decades, but a looming $48 billion acquisition and razor-thin cash flow coverage are putting that streak under pressure most income investors haven't noticed yet.
While nervous investors obsess over a handful of tech giants propping up the whole market, one portfolio manager keeps funneling fresh cash into the brands sitting in every American medicine cabinet, and…
Bond yields are rising fast enough to rattle stocks. The 10-year Treasury yield now stands at 5.24%. When rates rise and valuations wobble, the most reliable income comes from companies that sell…
One of these stocks lost nearly a fifth of its value over the past year, another nearly doubled, and both still handed shareholders a bigger check. Find out whether the dividends behind…
Kimberly-Clark just logged its 54th straight year of dividend increases, but a shrinking raise, falling free cash flow, and a massive acquisition in progress raise a pointed question for income investors living…
Rising rates have boomers flocking to Treasuries, but five battle-tested dividend payers with 50-plus years of consecutive increases may offer something bonds simply cannot deliver.
Kimberly-Clark (NASDAQ:KMB | KMB Price Prediction) pays a quarterly dividend of $1.28 per share. That is an annualized forward rate of $5.12 and a yield of 5.16%. The problem sits right next…
Colgate-Palmolive has sent dividend checks without interruption since Grover Cleveland's second term, but a 130-year streak and a shrinking North American business now sit in uncomfortable tension with a premium valuation that…
Kimberly-Clark hands retirees a fatter dividend check every quarter, but one look at what sits behind that payout changes the picture fast. Before you choose the bigger yield, consider what happens when…
Kimberly-Clark just logged 54 straight years of dividend raises, but a closer look at the cash flow statement raises an uncomfortable question about who is actually funding that growing payout.
While investors pile into pricey AI darlings, a handful of battle-tested Dividend Kings have quietly slipped to levels that scream value, and Wall Street analysts see serious upside ahead for 2027.
Both Clorox and Kimberly-Clark have raised their dividends for years and offer yields above 5%, but one of them is sitting on a payout that its own management quietly admits may not…
Younger investors are rewriting the rules of wealth building, and five overlooked dividend stocks under $20 sit right at the center of that shift. The real question is whether these picks can…
Kimberly-Clark just raised its dividend for the 54th straight year while simultaneously chasing a nearly $50 billion acquisition, and income investors are now weighing whether a deal of that size can coexist…
Kimberly-Clark Corporation is a global consumer products company that manufactures and markets essential personal care, consumer tissue, and professional products.
24/7 Wall St.'s 12-month price target for KMB is $118.08, rated Buy. The Wall Street consensus target is $115.27. KMB price prediction →
